Biotech
Gameto
Gameto raises $44M Series C at $250M valuation
$44M
Total Raised
Series C
Latest Round
2020
Founded
60+
Employees
Austin, TX
1 min read
Quick Facts
Valuation
$250M
Latest Round Size
$44M
Latest Round Date
September 2025
Gameto: Series C Funding Round
Gameto has successfully raised $44M in Series C funding, reaching a valuation of $250M.
Company Overview
Stem cell-derived therapies for reproductive health
Funding Details
The Series C round was led by Future Ventures, with participation from Khosla Ventures.
Company Information
- Headquarters: Austin, TX
- Founded: 2020
- Employees: 60+
- Category: Biotech
Investment
Gameto plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Future Ventures: Verified investor in Series C
- Khosla Ventures: Verified investor in Series C
Key Investors
Future Ventures
Lead Investor
Verified investor in Series C
Khosla Ventures
Investor
Verified investor in Series C
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M